Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07794111 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects.

Name: A Clinical Trial of TQF6422 Injection in Overweight or Obese Healthy Subjects. — clinical trial record (NCT07794111)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorShanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Started2026-09

View on ClinicalTrials.gov ↗

This is a placebo-controlled, double-blind trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of TQF6422 Injection in overweight or obese healthy participants.

Trial Details

NCT Number	NCT07794111
Lead Sponsor	Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Conditions	Obesity / Overweight
Enrollment	108 participants
Start Date	2026-09
Primary Completion	2028-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-08-31